Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome

Clinical Infectious Diseases

Volumn 34, Issue 3, 2002, Pages 293-304

  Chapman, L E ^a   Ellis, B A ^a,b   Koster, F T ^c   Sotir, M ^a   Ksiazek, T G ^a   Mertz, G J ^c   Rollin, P E ^a   Baum, K F ^a,d   Pavia, A T ^e   Christenson, J C ^e   Rubin, P J ^f   Jolson, H M ^a,g   Behrman, R E ^g   Khan, A S ^a   Wilson Bell, L J ^a   Simpson, G L ^h   Hawk, J ^a   Holman, R C ^a   Peters, C J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f Infectious Diseases Consultants Ltd   (United States)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h NEW MEXICO DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMOCONCENTRATION; HOSPITALIZATION; HUMAN; HYPOCAPNIA; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MYALGIA; NAUSEA; OUTPATIENT; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; THROMBOCYTOPENIA; UNITED STATES;

ANTIVIRAL AGENTS; BLOOD GAS ANALYSIS; ELECTROLYTES; FEMALE; HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; LUNG DISEASES; MALE; PLATELET COUNT; PROTHROMBIN TIME; REGRESSION ANALYSIS; RIBAVIRIN; TIME FACTORS;

EID: 0036467252     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/324619     Document Type: Article

References (16)

1. Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during one year of open label experience
2. Outbreak of acute illness - Southwestern United States 1993
3. Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses
4. Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease
5. Cardiopulmonary manifestations of the hantavirus pulmonary syndrome
6. Hantavirus pulmonary syndrome: Pathogenesis of an emerging infectious disease
7. Hantavirus pulmonary syndrome - Colorado and New Mexico, 1998
8. Hantavirus pulmonary syndrome in Florida: Association with the newly identified Black Creek Canal virus
9. Hantavirus pulmonary syndrome, renal insufficiency and myositis associated with infection by Bayou hantavirus
10. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review
11. Hantaviruses
12. Hantavirus pulmonary syndrome: Clinical, diagnostic and virologic aspects